REG - Fevertree Drinks PLC - Director/PDMR Shareholding

Fevertree DrinksAnnouncement

18/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220718:nRSR7182Sa&default-theme=true

RNS Number : 7182S  Fevertree Drinks PLC  18 July 2022

18 July 2022

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Director/PDMR Shareholding

 

Fever-Tree, the world's leading supplier of premium carbonated mixers,
announces that on 15 July 2022, Jeff Popkin, a Non-Executive Director of the
Company, bought, in aggregate, 15,208 ordinary shares in the Company at a
price of USD 10.45 per ordinary share via the US OTC Markets.

 

 Ends

 

For further information:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44
(0)743 582 8138

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024

 

Nominated Advisor and Joint Broker - Numis Securities

Stuart Dickson I Hugo Rubinstein I +44 (0)20 7260 1000

 

Joint Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

 

Financial PR advisers - Finsbury

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233;
Carolina Neri +44 (0)7502 127 516

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                           Jeff Popkin
 2   Reason for the notification
 a)  Position/status                                                Non-Executive Director
 b)  Initial notification/Amendment                                 Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                           Fevertree Drinks plc
 b)  LEI                                                            2138007AJRLHRVQZLD07
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument    Fever-Tree equity trading OTC as FQVTF

     Identification code
                                                                     GB00BRJ9BJ26
 b)  Nature of the transaction                                      Acquisition of FQVTF equity via OTC
 c)  Price(s) and volume(s)                                         Price (USD)  Volume
                                                                    1.  $10.45       15,208
 d)  Aggregated information                                         As above
 e)  Date of the transaction                                        15 July 2022
 f)  Place of the transaction                                       US OTC Market

b)

LEI

2138007AJRLHRVQZLD07

4

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

   Fever-Tree equity trading OTC as FQVTF

   GB00BRJ9BJ26

b)

Nature of the transaction

Acquisition of FQVTF equity via OTC

c)

Price(s) and volume(s)

     Price (USD)  Volume
 1.  $10.45       15,208

d)

Aggregated information

As above

e)

Date of the transaction

15 July 2022

f)

Place of the transaction

US OTC Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBRGDRIDBDGDU